Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson
NC, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT. The pregnane
X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.
Mol Endocrinol 2000;14:27–39.
Kafert-Kasting S, Alexandrova K, Barthold M, Laube B, Friedrich G, Arseniev L,
Hengstler JG. Enzyme induction in cryopreserved human hepatocyte cultures.
Toxicology 2006;220:117–125.
Kato M, Chiba K, Horikawa M, Sugiyama Y. The quantitative prediction ofin vivo
enzyme-induction caused by drug exposure fromin vitroinformation on human
hepatocytes. Drug Metab Pharmacokinet 2005;20:236–243.
Kirby GM, Batist G, Alpert L, Lamoureux E, Cameron RG, Alaoui-Jamali MA.
Overexpression of cytochrome P450 isoforms involved in aflatoxin B1 bioactivation
in human liver with cirrhosis and hepatitis. Toxicol Pathol 1996;24:458–467.
Klaassen CD, Slitt AL. Regulation of hepatic transporters by xenobiotic receptors. Curr
Drug Metab 2005;6:309–328.
Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD,
Oliver BB, Willson TM, Zetterstrom RH, Perlmann T, Lehmann JM. An orphan
nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.
Cell 1998;92:73–82.
Kliewer SA, Willson TM. Regulation of xenobiotic and bile acid metabolism by the
nuclear pregnane X receptor. J Lipid Res 2002;43:359–364.
Kocarek TA, Schuetz EG, Strom SC, Fisher RA, Guzelian PS. Comparative analysis of
cytochrome P4503A induction in primary cultures of rat, rabbit, and human
hepatocytes. Drug Metab Dispos 1995;23:415–421.
Kostrubsky VE, Ramachandran V, Venkataramanan R, Dorko K, Esplen JE, Zhang S,
Sinclair JF, Wrighton SA, Strom SC. The use of human hepatocyte cultures to study
the induction of cytochrome P450. Drug Metab Dispos 1999;27:887–894.
LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallee F, Narang PK.
Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and
norethindrone. J Clin Pharmacol 1998;38:1042–1050.
LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, Parkinson A. Expression
and regulation of cytochrome P450 enzymes in primary cultures of human
hepatocytes. J Biochem Mol Toxicol 2000;14:177–188.
LeCluyse EL. Pregnane X receptor: molecular basis for species differences in CYP3A
induction by xenobiotics. Chem Biol Interact 2001a;134:283–289.
LeCluyse EL. Human hepatocyte culture systems for the in vitro evaluation of
cytochrome P450 expression and regulation. Eur J Pharm Sci 2001b;13:343–368.
Ledirac N, de Sousa G, Fontaine F, Agouridas C, Gugenheim J, Lorenzon G,
Rahmani R. Effects of macrolide antibiotics on CYP3A expression in human and
rat hepatocytes: interspecies differences in response to troleandomycin. Drug Metab
Dispos 2000;28:1391–1393.
Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human
orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene
expression and cause drug interactions. J Clin Invest 1998;102:1016–1023.
Lu C, Li AP. Species comparison in P450 induction: effects of dexamethasone,
omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured
568 TESTING DRUG CANDIDATES FOR CYP3A4 INDUCTION